{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:18:44Z","timestamp":1754151524042,"version":"3.41.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To evaluate current anti-Ro and anti-La autoantibody ordering patterns, clinical indications for performing these tests, and potential cost\u2013benefit analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective cohort study, patients who underwent autoantibody testing over 1\u00a0year were included. Necessary information was obtained from patient electronic records.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total 47 patients underwent anti-Ro\/La autoantibody testing. Of those tested, 11\/47 (2%) had positive results and testing was clinically indicated in 26\/47 (55%) patients, indicating minimal cost-benefits. The total rate of the cost prescription was \u20ac1644.96. The mean time to process tests was 5\u00a0days. In those with positive autoantibodies, two infants were diagnosed with congenital heart block and had pacemakers inserted after delivery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study found anti-Ro\/La autoantibody tests were appropriately ordered in accordance with clinical guidelines. By identifying patients who were autoantibody negative, economic benefits were gained, in terms of antenatal management including reduced frequency of antenatal visits and fetal heart surveillance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11845-025-03935-2","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:59:33Z","timestamp":1742659173000},"page":"989-993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 1-year review of anti-Ro\/La autoantibody testing in an obstetric population"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-7622","authenticated-orcid":false,"given":"Elizabeth","family":"Tunney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare M.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire M.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etaoin","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"3935_CR1","doi-asserted-by":"publisher","unstructured":"Brito-Zer\u00f3n P, Izmirly PM, Ramos-Casals M et al (2015) The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 11(5):301\u201312. https:\/\/doi.org\/10.1038\/nrrheum.2015.29","DOI":"10.1038\/nrrheum.2015.29"},{"issue":"24","key":"3935_CR2","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","volume":"55","author":"E Jaeggi","year":"2010","unstructured":"Jaeggi E, Laskin C, Hamilton R et al (2010) The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55(24):2778\u20132784. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.042","journal-title":"J Am Coll Cardiol"},{"key":"3935_CR3","unstructured":"Tunaoglu FS, Yildirim A, Vurali D (2010) Isolated congenital heart block. Tex Heart Inst J 37(5):579\u201383"},{"issue":"4","key":"3935_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE et al (2020A) 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72(4):529\u2013556. https:\/\/doi.org\/10.1002\/art.41191","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3935_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","volume":"76","author":"P Izmirly","year":"2020","unstructured":"Izmirly P, Kim M, Friedman DM et al (2020) Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers. J Am Coll Cardiol 76(3):292\u2013302. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.045","journal-title":"J Am Coll Cardiol"},{"key":"3935_CR6","doi-asserted-by":"publisher","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","DOI":"10.1136\/annrheumdis-2016-209770"},{"issue":"5","key":"3935_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10067-012-2141-y","volume":"32","author":"A Man","year":"2013","unstructured":"Man A, Shojania K, Phoon C et al (2013) An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol 32(5):601\u2013608. https:\/\/doi.org\/10.1007\/s10067-012-2141-y","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3935_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jbspin.2020.05.007","volume":"87","author":"A Ahrari","year":"2020","unstructured":"Ahrari A, Barrett SS, Basharat P et al (2020) Appropriateness of laboratory tests in the diagnosis of inflammatory rheumatic diseases among patients newly referred to rheumatologists. Joint Bone Spine 87(6):588\u2013595. https:\/\/doi.org\/10.1016\/j.jbspin.2020.05.007","journal-title":"Joint Bone Spine"},{"issue":"9","key":"3935_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan EM, Feltkamp TE, Smolen JS et al (1997) Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheum 40(9):1601\u20131611. https:\/\/doi.org\/10.1002\/art.1780400909","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3935_CR10","doi-asserted-by":"publisher","first-page":"e000520","DOI":"10.1136\/rmdopen-2017-000520","volume":"3","author":"S Meisgen","year":"2017","unstructured":"Meisgen S, Tingstr\u00f6m J, Skog Andreasson A (2017) Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro\/SSA-positive women. RMD Open 3(2):e000520. https:\/\/doi.org\/10.1136\/rmdopen-2017-000520","journal-title":"RMD Open"},{"key":"3935_CR11","unstructured":"Gorman \u00c1, Moore L, O\u2019Brien C et al (2023) Management of rheumatic diseases in the preconception, antenatal and postnatal periods. National Women and Infants Health Programme and The Institute of Obstetricians and Gynaecologists.\u00a0"},{"issue":"4","key":"3935_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666X.2022.2050216)","volume":"18","author":"C Nalli","year":"2022","unstructured":"Nalli C, Manfredi L, Fredi M et al (2022) Managing puerperium in patients with systemic autoimmune diseases: an update. Expert Rev Clin Immunol 18(4):391\u2013399. https:\/\/doi.org\/10.1080\/1744666X.2022.2050216)","journal-title":"Expert Rev Clin Immunol"},{"key":"3935_CR13","doi-asserted-by":"publisher","unstructured":"Pri-Paz Basson Y, Neumark E, Kivity S, Tayer-Shifman OE (2024) Mitigating overuse of antinuclear antibody (ANA) testing through educational intervention: a study in internal medicine and neurology departments. Clin Rheumatol 43(12):3935\u20133939. https:\/\/doi.org\/10.1007\/s10067-024-07180-3","DOI":"10.1007\/s10067-024-07180-3"},{"key":"3935_CR14","doi-asserted-by":"publisher","unstructured":"Mahler M, Meroni PL, Bossuyt X, Fritzler MJ (2014) Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 315179. https:\/\/doi.org\/10.1155\/2014\/315179","DOI":"10.1155\/2014\/315179"},{"key":"3935_CR15","doi-asserted-by":"publisher","unstructured":"Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4:S1\u20135. https:\/\/doi.org\/10.1186\/ar551","DOI":"10.1186\/ar551"},{"issue":"2","key":"3935_CR16","doi-asserted-by":"publisher","first-page":"e001727","DOI":"10.1136\/rmdopen-2021-001727","volume":"7","author":"HTW Smeele","year":"2021","unstructured":"Smeele HTW, Schreurs MWJ, Costedoat-Chalumeau N, Cornette JMJ, Dolhain RJEM (2021) Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive. RMD Open 7(2):e001727. https:\/\/doi.org\/10.1136\/rmdopen-2021-001727","journal-title":"RMD Open"},{"key":"3935_CR17","doi-asserted-by":"publisher","unstructured":"Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 3;126(1):76\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.089268","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"3935_CR18","doi-asserted-by":"publisher","unstructured":"Saxena A, Izmirly PM, Mendez B, Buyon JP, Friedman DM (2014) Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev 22(6):263\u20137. https:\/\/doi.org\/10.1097\/CRD.0000000000000026","DOI":"10.1097\/CRD.0000000000000026"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03935-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-03935-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03935-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:19:04Z","timestamp":1752898744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-03935-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-03935-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Rotunda Hospital Ethics committee approved this study (REF no 22\/010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}